Evidence map›Paper›PMID 42898464›Full record

ArticleFrontiers in bioinformatics2026

How AI-based techniques for brain tumour diagnosis can address data variability.

Paola Lecca, Michela Lecca

Abstract read
In one paragraph

Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paola LeccaFaculty of Engineering, Free University of Bozen-Bolzano, Bolzano-Bozen, Italy.
Michela LeccaTechnologies of Vision, Fondazione Bruno Kessler, Trento, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data variability in medical imaging of tumors refers to the inconsistencies in Magnetic Resonance Imaging and Computational Tomography scans caused by heterogeneous tumor biology, varying scanner hardware, and subjective human interpretation. This variability creates significant challenges for accurate diagnoses, treatment tracking, and AI model development. Although the variability in medical imaging data for diagnostic and prognostic purposes is a challenge for AI methods applied to other types of tumors as well, it is particularly problematic when the analysis involves gliomas and glioblastomas. Most gliomas are infiltrative and glioblastomas are highly infiltrative tumors with poorly defined margins. They exhibit significant regional variations, including cystic necrosis, localized hemorrhages, and complex microvascular proliferation. Addressing this variability requires a combination of algorithmic innovation, standardized datasets, and a leading-edge computational pipeline including traditional and AI-based data modelling methodologies to ensure diagnostic and prognostic models are robust. In this article, we will identify some AI methods that show promise in the analysis of brain tumor images and that must overcome the challenges posed by data availability. We will also offer some insights into how these challenges can be overcome and propose a possible computational pipeline that utilizes them.

Indexed as

data integrationdata standardizationdeep learningexplainable AIgliomamedical imagingmultimodal model fusionradiomics

Identifiers

PMID42898464
PMCPMC13677829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.